{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:31:52Z","timestamp":1791891112324,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.jaad.2005.04.035","type":"journal-article","created":{"date-parts":[[2005,6,19]],"date-time":"2005-06-19T07:07:29Z","timestamp":1119164849000},"page":"S94-S100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":152,"special_numbering":"S","title":["Psoriasis\u2014recent advances in understanding its pathogenesis and treatment"],"prefix":"10.1016","volume":"53","author":[{"given":"Gerald","family":"Krueger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2005.04.035_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1067\/mjd.2000.106374","article-title":"Two considerations for patients with psoriasis and their clinicians: What defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?","volume":"43","author":"Krueger","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib2","series-title":"Handbook of psoriasis","first-page":"7","article-title":"Clinical variants of psoriasis","author":"Camisa","year":"1998"},{"key":"10.1016\/j.jaad.2005.04.035_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0190-9622(93)70206-9","article-title":"Psoriasis in Australian twins","volume":"29","author":"Duffy","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2340\/0001555562229236","article-title":"Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution","volume":"62","author":"Brandrup","year":"1982","journal-title":"Acta Derm Venereol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.035_bib5","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/S0190-9622(03)01135-6","article-title":"Genetics of psoriasis: the potential impact on new therapies","volume":"49","author":"Bowcock","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/hmg\/11.5.589","article-title":"Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus","volume":"11","author":"Asumalahti","year":"2002","journal-title":"Hum Mol Gene"},{"key":"10.1016\/j.jaad.2005.04.035_bib7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1523-1747.2002.01749.x","article-title":"Searching for the major histocompatibility complex psoriasis susceptibility gene","volume":"118","author":"Capon","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1086\/377159","article-title":"The International Psoriasis Genetics Consortium. The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs","volume":"73","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2005.04.035_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/86867","article-title":"Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci","volume":"27","author":"Cookson","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2005.04.035_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/319518","article-title":"A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases","volume":"68","author":"Jawaheer","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2005.04.035_bib11","doi-asserted-by":"crossref","first-page":"10746","DOI":"10.1073\/pnas.95.18.10746","article-title":"New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study","volume":"95","author":"Cornelis","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2005.04.035_bib12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1067\/mjd.2003.540","article-title":"Connections between psoriasis and Crohn's disease","volume":"48","author":"Najarian","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib13","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/hmg\/6.8.1349","article-title":"Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan","volume":"6","author":"Nair","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"Suppl 3","key":"10.1016\/j.jaad.2005.04.035_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/12034754020060S302","article-title":"Pathophysiology of psoriasis: science behind therapy","volume":"6","author":"Guenther","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2005.04.035_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00403-002-0349-4","article-title":"Natural killer and natural killer-T cells in psoriasis","volume":"294","author":"Cameron","year":"2002","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2005.04.035_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM199101313240501","article-title":"Cyclosporine for plaque-type psoriasis. results of a multidose, double-blind trial","volume":"324","author":"Ellis","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2005.04.035_bib17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2165\/00003495-199345060-00007","article-title":"Cyclosporin. a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders","volume":"45","author":"Faulds","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2005.04.035_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/1523-1747.ep12529841","article-title":"Characterization of mononuclear cell infiltrates in psoriatic lesions","volume":"71","author":"Bjerke","year":"1978","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib19","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1136\/bmj.300.6736.1398-c","article-title":"Psoriasis and bone marrow transplantation","volume":"300","author":"Jowitt","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2005.04.035_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2133.1997.17821869.x","article-title":"Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity","volume":"137","author":"Snowden","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib21","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/archderm.1990.01670350139033","article-title":"Psoriasis after allogeneic bone marrow transplantation","volume":"126","author":"Gardembas-Pain","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib22","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S0190-9622(03)01134-4","article-title":"The immunology of psoriasis and biologic immunotherapy","volume":"49","author":"Mehlis","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","article-title":"Psoriasis","volume":"361","author":"Lebwohl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2005.04.035_bib24","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/archderm.1988.01670120027005","article-title":"Interleukin 2 and psoriasis","volume":"124","author":"Lee","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib25","doi-asserted-by":"crossref","first-page":"23358","DOI":"10.1074\/jbc.274.33.23358","article-title":"Apoptosis in proliferating, senescent, and immortalized keratinocytes","volume":"274","author":"Chaturvedi","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2005.04.035_bib26","first-page":"264","article-title":"TNF-alpha and apoptosis: implications for the pathogenesis and treatment of psoriasis","volume":"1","author":"Victor","year":"2002","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib27","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/mjd.2003.554","article-title":"Etanercept: an overview","volume":"49","author":"Goffe","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/1523-1747.ep12283594","article-title":"Cell kinetic basis for pathophysiology of psoriasis","volume":"85","author":"Weinstein","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0738-081X(95)93817-8","article-title":"Altered keratinocyte growth and differentiation in psoriasis","volume":"13","author":"McKay","year":"1995","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0140-6736(91)92168-2","article-title":"Keratinocytes as initiators of inflammation","volume":"337","author":"Barker","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2005.04.035_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0625.2000.009001001.x","article-title":"Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop","volume":"9","author":"Terui","year":"2000","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib32","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","article-title":"Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis","volume":"180","author":"Detmar","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2005.04.035_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2133.1995.tb08702.x","article-title":"The endothelium in psoriasis","volume":"132","author":"Lowe","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1523-1747.ep12555746","article-title":"Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro","volume":"98","author":"Detmar","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s004030050299","article-title":"An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis","volume":"290","author":"Terajima","year":"1998","journal-title":"Arch Dermatol Res"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.035_bib36","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/mjd.2003.545","article-title":"Psoriasis treatment 2003 at the new millennium: position paper on behalf of authors","volume":"49","author":"Menter","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM200107263450403","article-title":"Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes","volume":"345","author":"Ellis","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.035_bib38","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/mjd.2003.552","article-title":"Development and use of alefacept to treat psoriasis","volume":"49","author":"Krueger","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.035_bib39","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/S0190-9622(03)01141-1","article-title":"Efalizumab: an overview","volume":"49","author":"Leonardi","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib40","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI1476","article-title":"IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach","volume":"101","author":"Asadullah","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2005.04.035_bib41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.0022-202x.2001.01317.x","article-title":"Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings","volume":"116","author":"Asadullah","year":"2001","journal-title":"J Invest Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.035_bib42","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/S0190-9622(03)01143-5","article-title":"Infliximab for psoriasis","volume":"49","author":"Gottlieb","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1396-0296.2004.04045.x","article-title":"Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritis","volume":"17","author":"Patel","year":"2004","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2005.04.035_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0022-4731(88)90080-5","article-title":"Glucocorticoid effects on the production and actions of immune cytokines","volume":"30","author":"Guyre","year":"1988","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.jaad.2005.04.035_bib45","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(89)90237-7","article-title":"Gene regulation by steroid hormones","volume":"56","author":"Beato","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2005.04.035_bib46","series-title":"Therapy of moderate-to-severe psoriasis","first-page":"179","article-title":"Combination, rotational, and sequential therapy","author":"Lebwohl","year":"2003"},{"key":"10.1016\/j.jaad.2005.04.035_bib47","series-title":"Therapy of moderate-to-severe psoriasis","first-page":"115","article-title":"Methotrexate treatment","author":"Weinstein","year":"2003"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.035_bib48","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S0190-9622(03)01139-3","article-title":"Phototherapy treatment of psoriasis today","volume":"49","author":"Zanolli","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.035_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0781.1999.tb00048.x","article-title":"PUVA-induced lymphocyte apoptosis: mechanism of action in psoriasis","volume":"15","author":"Coven","year":"1999","journal-title":"Photodermatol Photoimmunol Photomed"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205013137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205013137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:37:16Z","timestamp":1759268236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962205013137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0190962205013137"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2005.04.035","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis\u2014recent advances in understanding its pathogenesis and treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2005.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}